Table 3.
Group | ||||||||
CBT – AP | OBT – AP | |||||||
Variable | ES T1–T2 | ES T1–T3 | ES T1–T4 | ES T1–T4a | ES T1–T2 | ES T1–T3 | ES T1–T4 | ES T1–T4a |
FIQ – Physical impairment | 0.18 | 0.83 | 0.84 | 0.71 | 0.21 | 0.37 | 1.15 | 1.07 |
MPI – Pain | 0.29 | 0.40 | 1.14 | 0.31 | 0.33 | 0.30 | 1.10 | 0.62 |
MPI – Affective distress | 0.76 | 1.39 | 1.57 | 0.61 | 0.22 | 0.59 | 0.86 | 0.72 |
PRSS – Coping | 1.16 | 1.72 | 2.66 | 1.70 | 0.21 | 0.73 | 1.23 | 0.38 |
PRSS – Catastrophising | 0.62 | 0.96 | 1.44 | 0.54 | 0.12 | 0.89 | 0.97 | 0.41 |
Pain behaviour | 0.44 | 0.42 | 0.57 | 0.49 | 0.59 | 0.72 | 1.89 | 1.48 |
MPI – Solicitous spouse behaviour | 0.19 | 0.41 | 0.44 | 0.37 | 0.43 | 1.00 | 1.71 | 0.57 |
aAdjusted ES based on the AP group with the dropout values from baseline carried forward to the 12-month follow-up. Medium (>0.5) and large (>0.8) ESs were bolded. AP, attention-placebo; CBT, cognitive behaviour therapy; ES, effect size; FIQ, Fibromyalgia Impact Questionnaire, MPI, Multidimensional Pain Inventory; OBT, operant behavior therapy; PRSS, Pain Related Self-Statements Scale.